tiprankstipranks
Trending News
More News >
Trigyn Technologies Limited (IN:TRIGYN)
:TRIGYN
India Market

Trigyn Technologies Limited (TRIGYN) AI Stock Analysis

Compare
0 Followers

Top Page

IN:TRIGYN

Trigyn Technologies Limited

(TRIGYN)

Select Model
Select Model
Select Model
Neutral 55 (OpenAI - 5.2)
,
Neutral 55 (OpenAI - 5.2)
,
Neutral 55 (OpenAI - 5.2)
,
Neutral 55 (OpenAI - 5.2)
,
Neutral 55 (OpenAI - 5.2)
Rating:55Neutral
Price Target:
₹51.00
▼(-33.66% Downside)
Action:ReiteratedDate:03/19/26
The score is anchored by solid financial stability (strong balance sheet and improved cash flow), but is meaningfully reduced by weak technical momentum (below key moving averages with negative MACD) and an expensive valuation (very high P/E with no dividend yield provided).
Positive Factors
Strong balance sheet
Low debt and a high equity ratio materially reduce financial risk and preserve borrowing capacity. This balance-sheet strength provides a durable buffer to absorb billing delays, support multi-quarter contract delivery, and fund selective investments or hiring without stressing liquidity.
Improving free cash flow
An improvement in free cash flow enhances internal liquidity and reduces reliance on external funding. For a services company, stronger FCF supports steady payroll and subcontractor payments, funds reinvestment in sales/technology, and helps smooth seasonality across the next several quarters.
Healthy gross profit margin
A solid gross margin indicates efficient delivery and some pricing power in core services, which underpins long-term margin sustainability. If operating costs are managed, healthy gross margins provide room to recover EBIT and net margins and support sustainable profitability improvements.
Negative Factors
Inconsistent revenue growth
Intermittent or negative top-line growth undermines utilization planning and scale economics in a staffing-driven IT services model. Persistent revenue weakness complicates capacity decisions, reduces near-term contract leverage, and makes multi-quarter recovery dependent on durable new contract wins.
Weak profitability trends
Sharp EPS contraction and falling operating margins suggest margin pressure from pricing, cost inflation, or execution issues. Eroding profitability limits reinvestment, may force cost cuts that harm growth initiatives, and makes sustained margin recovery more challenging over the medium term.
Volatile operating cash flow
Fluctuating operating cash flow signals uneven billing, collections, or project execution, increasing working-capital risk. This volatility can necessitate short-term financing during downturns, reducing flexibility to invest in sales, talent, or platform improvements over the next several quarters.

Trigyn Technologies Limited (TRIGYN) vs. iShares MSCI India ETF (INDA)

Trigyn Technologies Limited Business Overview & Revenue Model

Company DescriptionTrigyn Technologies Limited (TRIGYN) is a global provider of information technology services and solutions, specializing in software development, IT consulting, and staffing services. The company operates across various sectors, including government, healthcare, finance, and manufacturing, offering a range of core products and services such as enterprise application development, systems integration, and IT infrastructure management.
How the Company Makes MoneyTrigyn primarily makes money by delivering IT services under client contracts. Key revenue streams typically include: (1) project-based services where the company designs, builds, and/or maintains software applications and charges clients based on agreed milestones, deliverables, or fixed-price/time-and-material terms; (2) staffing and resource augmentation (including managed staffing) where it supplies IT professionals to client teams and earns fees billed on hourly/daily/monthly rates or managed service arrangements; and (3) ongoing support and maintenance services that generate recurring revenue through service contracts/retainers for managing and enhancing existing applications and IT systems. Revenue is driven by contract wins, utilization of billable staff, pricing/realization rates, and the scale/duration of client engagements. Specific material partnerships or customer concentration details: null.

Trigyn Technologies Limited Financial Statement Overview

Summary
Financials are mixed: a strong, low-debt balance sheet (78) and improving but volatile cash flow (70) offset weaker income statement trends (65) with inconsistent revenue growth and pressured profitability.
Income Statement
65
Positive
Trigyn Technologies has experienced fluctuations in revenue and profitability. The recent drop in revenue and net income signals potential challenges in maintaining growth. Gross profit margin is healthy, but declining EBIT and net profit margins indicate pressure on profitability. Revenue growth has been inconsistent, highlighting the need for strategic adjustments to sustain long-term growth.
Balance Sheet
78
Positive
The company maintains a strong financial position with a high equity ratio and low debt levels, reflecting stability and reduced financial risk. The debt-to-equity ratio remains favorable, indicating conservative leverage. However, a decrease in stockholders' equity growth rate suggests potential challenges in value creation. Overall, the balance sheet showcases financial prudence.
Cash Flow
70
Positive
Cash flow analysis reveals a mixed performance with strong free cash flow generation in the latest period compared to previous years. However, the volatility in operating cash flow and previous periods of negative free cash flow highlight potential operational inefficiencies that need addressing. The recent improvement provides a good starting point for enhancing cash flow stability.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue9.14B8.98B12.80B12.73B10.41B9.85B
Gross Profit3.18B4.13B4.58B4.20B3.15B3.04B
EBITDA215.41M342.52M467.44M672.79M671.35M938.87M
Net Income44.56M117.69M199.63M346.77M390.72M621.73M
Balance Sheet
Total Assets9.16B9.03B8.74B8.56B7.55B6.83B
Cash, Cash Equivalents and Short-Term Investments4.13B4.23B3.36B1.38B2.15B1.96B
Total Debt67.42M127.60M46.98M67.83M73.56M102.27M
Total Liabilities1.55B1.62B1.72B1.75B1.47B1.25B
Stockholders Equity7.62B7.41B7.01B6.81B6.08B5.58B
Cash Flow
Free Cash Flow-620.88M513.66M1.25B-576.57M292.02M771.81M
Operating Cash Flow-612.72M514.92M1.26B-520.73M449.63M802.23M
Investing Cash Flow114.16M157.48M682.98M-628.59M-314.57M-14.27M
Financing Cash Flow-12.48M-34.55M-37.42M-28.16M-56.37M-45.95M

Trigyn Technologies Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price76.88
Price Trends
50DMA
56.52
Negative
100DMA
63.61
Negative
200DMA
72.35
Negative
Market Momentum
MACD
-2.94
Negative
RSI
36.85
Neutral
STOCH
52.32
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:TRIGYN, the sentiment is Negative. The current price of 76.88 is above the 20-day moving average (MA) of 49.75, above the 50-day MA of 56.52, and above the 200-day MA of 72.35, indicating a bearish trend. The MACD of -2.94 indicates Negative momentum. The RSI at 36.85 is Neutral, neither overbought nor oversold. The STOCH value of 52.32 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:TRIGYN.

Trigyn Technologies Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
₹1.98B28.040.84%-10.39%-52.44%
66
Neutral
₹1.89B11.6020.62%1.68%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
56
Neutral
₹1.50B63.140.26%9.12%22.53%
55
Neutral
₹1.46B74.37-16.31%-9.79%
55
Neutral
₹2.87B40.24-6.88%
54
Neutral
₹1.56B-6.200.49%30.15%330.45%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:TRIGYN
Trigyn Technologies Limited
47.32
-30.35
-39.08%
IN:3IINFOLTD
3i Infotech Limited
13.83
-8.62
-38.40%
IN:AARTECH
Aartech Solonics Ltd.
47.14
-7.79
-14.18%
IN:DEVIT
Dev Information Technology Ltd
27.71
-19.82
-41.70%
IN:DRCSYSTEMS
DRC Systems India Limited
13.15
-11.17
-45.93%
IN:INTENTECH
Intense Technologies Limited
84.00
-17.24
-17.03%

Trigyn Technologies Limited Corporate Events

Trigyn Technologies Chairman Dr. Satyam Cherukuri to Step Down in April 2026
Mar 9, 2026

Trigyn Technologies Limited has announced that Chairman and Non-Executive Director Dr. Satyam Cherukuri has resigned from the board, effective April 7, 2026, citing personal circumstances requiring his full attention. He will also step down from the board of subsidiary Trigyn Technologies Inc., with the company formally recording its appreciation for his contributions during his tenure.

The departures mark a notable change in the company’s leadership structure at both the parent and subsidiary levels, and Trigyn has disclosed the move under SEBI’s Listing Obligations and Disclosure Requirements. The company has not yet announced a successor, leaving investors and other stakeholders awaiting clarity on future board composition and governance continuity.

Trigyn Technologies Closes Trading Window Ahead of Q3 FY26 Results
Dec 26, 2025

Trigyn Technologies Limited has announced that it will close its trading window for designated persons, their immediate relatives and other insiders from 1 January 2026, in line with SEBI’s Prohibition of Insider Trading Regulations and the company’s internal code of conduct. The restriction, which includes freezing the PANs of designated persons by NSDL, is tied to the preparation and approval of the company’s unaudited financial results for the quarter ended 31 December 2025, and will remain in force until 48 hours after these results are disclosed to the stock exchanges, underscoring the company’s efforts to ensure compliance and prevent insider trading ahead of a key earnings announcement.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 19, 2026